For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
The making of a health ‘boss girl’
+News
In print
The making of a health ‘boss girl’
Monday 21 March 2022, 10:13 AM

Lesley Clarke has left the NZMA after 10 years as chief executive – new horizons beckon [Image:Steve Montgomery]
Virginia McMillan profiles a leader and stalwart of the medico-political landscape in an ‘exit interview’
Lesley Clarke - Bio in brief, ACC – roles included Wellington branch manager, special projects manager, 1983–1996
GMV – consultancy, 1996–1997
NZMA – deputy chief executive, , BACK panel - grey
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.